股份有限公司-logo.jpg){kind=logo}
元码基因科技(北京)股份有限公司
Harnessing genomics technology to deliver precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics.
Harnessing genomics technology to deliver precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics.
Yuancode Gene Technology, founded in 2014, focuses on leveraging genomics technology to provide precise medical solutions and develop a clinical cancer platform grounded in bioinformatics and genomics. The company received a CNY10.00M Series A investment on 07 February 2017 from Source Capital and Tianjin Yahui Mingze Asset Management. Yuancode Gene Technology operates in the Health Care and Information Technology industries, aiming to revolutionize clinical practice with genomics technology. Their slogan encapsulates their mission to harness genomics for targeted medical solutions and innovative cancer treatment platforms.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY10.00M | 2 |
|
07 Feb 2017 |
| Angel Round | CNY3.00M | 2 | Huaren Yiyao Peisong, Huaren Chuangtou | 15 Mar 2016 |
No recent news or press coverage available for 元码基因科技(北京)股份有限公司.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
